Click chemistry has reshaped the landscape of peptide-oligonucleotide conjugation by introducing a family of reactions that are fast, quantitative, and bioorthogonal, meaning they proceed selectively between two non-natural functional groups without interfering with the amines, thiols, hydroxyls, or carboxylates present in biomolecules. For peptide-RNA conjugation, where conventional methods struggle with chemoselectivity, RNA degradation, and product heterogeneity, click reactions offer a compelling alternative. The three most widely adopted click chemistries for this application, copper-catalyzed azide-alkyne cycloaddition (CuAAC), strain-promoted azide-alkyne cycloaddition (SPAAC), and inverse electron-demand Diels-Alder (IEDDA) ligation, span a range of reaction rates, copper requirements, and synthetic accessibility. Understanding their distinct profiles allows researchers to match the click reaction to the sensitivity and scale of their specific conjugation project.
This article examines the mechanistic principles, practical protocols, and comparative performance of CuAAC, SPAAC, and IEDDA for peptide-RNA conjugation. It covers the installation of azide, alkyne, cyclooctyne, tetrazine, and trans-cyclooctene handles on peptides and RNA, strategies for mitigating copper toxicity and RNA oxidation, and the emerging role of click chemistry in producing homogeneous, site-specifically conjugated peptide-RNA constructs for research applications.
The defining challenge of peptide-RNA conjugation is not forming a covalent bond, many reactions can do that, but forming the right bond at the right site without collateral modification of the biological activity of either component. Conventional amide and thiol-based chemistries address this challenge incompletely. Amide coupling with activated esters modifies any accessible amine, including those on nucleobases. Thiol-maleimide chemistry achieves better selectivity but requires cysteine placement and a maleimide handle that is susceptible to hydrolysis. Click chemistry solves the selectivity problem entirely: by using azides, alkynes, strained cyclooctynes, tetrazines, and trans-cyclooctenes, functional groups that are absent from natural biomolecules, click reactions ensure that conjugation occurs exclusively at the positions where these handles have been synthetically installed.
| Click Reaction | Reactive Pair | Catalyst | Typical Rate Constant | Best For |
| CuAAC | Azide + Alkyne | Cu(I) + ligand | 10-200 M(-1)s(-1) | High-yield conjugation; azide/alkyne handles widely available |
| SPAAC | Azide + Cyclooctyne | None | 0.1-10 M(-1)s(-1) | Copper-sensitive RNA; live-cell compatible |
| IEDDA | Tetrazine + TCO | None | 10(2)-10(6) M(-1)s(-1) | Ultrafast conjugation at low concentration; in situ applications |
Table 1 Comparison of Three Click Chemistry Platforms for Peptide-RNA Conjugation
Three criteria define a bioorthogonal reaction suitable for peptide-RNA conjugation. First, selectivity: the reactive handles must not cross-react with the twenty natural amino acid side chains, the four RNA nucleobases, or the phosphodiester backbone. Azides, terminal alkynes, cyclooctynes, tetrazines, and trans-cyclooctenes satisfy this requirement because they are chemically inert toward biological nucleophiles and electrophiles under physiological conditions. Second, kinetics: the reaction must proceed fast enough at biologically relevant concentrations (micromolar to low millimolar) and temperatures (4-37 degrees Celsius) to achieve acceptable conversion within practical timeframes. CuAAC delivers moderate rates (hours), SPAAC is slower (hours to overnight), and IEDDA is exceptionally fast (seconds to minutes). Third, biocompatibility: the reaction conditions and byproducts must not damage the RNA cargo. This is the primary concern with CuAAC, where copper(I) ions generate reactive oxygen species that cleave RNA, and why SPAAC and IEDDA, both copper-free, are attractive for sensitive RNA constructs.
Every click reaction installs a specific heterocyclic linkage between the peptide and RNA that becomes a permanent structural feature of the conjugate. CuAAC and SPAAC both form 1,2,3-triazole rings, which are aromatic, planar, and chemically inert. The triazole is approximately isosteric with a trans-amide bond and contributes to conjugate rigidity at the linkage point. IEDDA ligation between tetrazine and TCO produces a dihydropyridazine linkage that rearranges to a mixture of isomers. These heterocycles are not biologically recognized or cleaved, making click ligations suitable for applications where the peptide and RNA must remain covalently associated throughout the conjugate's functional lifetime. For applications requiring intracellular release of the RNA, the click ligation must be paired with a cleavable linker element, such as a disulfide or cathepsin-sensitive peptide sequence, placed in series with the triazole or pyridazine linkage.
Click chemistry is not always necessary for peptide-RNA conjugation; for simple constructs with well-behaved peptides and short, chemically stable RNAs, conventional amide or thiol-maleimide methods may suffice. However, click chemistry becomes the preferred or required approach in several scenarios: when the peptide contains multiple competing nucleophiles that would produce heterogeneous amide coupling products; when the RNA is long or structurally complex and cannot tolerate nucleobase modification; when the peptide-RNA conjugate is destined for quantitative structure-activity relationship (QSAR) studies that demand chemically homogeneous material; when copper-free conditions are mandatory, such as for in situ conjugation in live cells; and when the conjugation must be completed in minutes at nanomolar concentrations, a regime accessible only to IEDDA chemistry.
The copper(I)-catalyzed azide-alkyne cycloaddition, the reaction that defined the field of click chemistry following its introduction by Sharpless and Meldal in 2002, remains the most widely used click reaction for peptide-oligonucleotide conjugation. Its enduring popularity stems from the commercial availability of azide and alkyne phosphoramidites for automated oligonucleotide synthesis, the small size of both handles (minimally perturbing to biomolecular recognition), and the robust, reliable protocols that have been developed over two decades of use. When properly optimized with copper-stabilizing ligands, CuAAC achieves high conversion with minimal RNA damage.
The CuAAC mechanism proceeds through a copper(I) acetylide intermediate: the terminal alkyne is deprotonated and coordinates to Cu(I), forming a copper acetylide that undergoes cycloaddition with the azide to yield the 1,4-disubstituted 1,2,3-triazole. The active catalytic species is Cu(I), which is thermodynamically unstable with respect to disproportionation to Cu(0) and Cu(II) in aqueous solution. For this reason, CuAAC reactions typically generate Cu(I) in situ by reducing Cu(II) salts, most commonly copper(II) sulfate, with sodium ascorbate. The ascorbate must be added fresh and in excess (typically 5-10 equivalents relative to copper) because it is consumed not only by copper reduction but also by dissolved oxygen. The key innovation that made CuAAC practical for biomolecular conjugation was the introduction of copper-stabilizing ligands. Tris(3-hydroxypropyltriazolylmethyl)amine (THPTA) and tris(benzyltriazolylmethyl)amine (TBTA) are the most commonly used accelerating ligands. THPTA is water-soluble and preferred for RNA conjugation because it accelerates the reaction, protects Cu(I) from oxidation, and, critically, scavenges the reactive oxygen species generated by copper-redox cycling. THPTA also permits a reduction in copper loading from the traditional 1 mM to as low as 100 micromolar, further reducing oxidative stress on the RNA.
A typical optimized CuAAC protocol for peptide-RNA conjugation proceeds as follows. The azide-modified peptide and alkyne-modified RNA are combined at 20-100 micromolar each in degassed phosphate or HEPES buffer (pH 7.0-7.5). Copper(II) sulfate is added to a final concentration of 100-500 micromolar, followed by THPTA ligand at a 5:1 molar ratio relative to copper. Sodium ascorbate (5 mM final) is added last to initiate the reaction. The mixture is incubated at room temperature for 1-2 hours with gentle agitation, protected from light. Reaction progress can be monitored by analytical HPLC or by denaturing PAGE. After completion, the conjugate is purified by reverse-phase HPLC or ethanol precipitation to remove copper, ligand, and ascorbate byproducts. An additional wash with EDTA-containing buffer (0.1 M EDTA, pH 7) may be included to chelate residual copper before the conjugate is used in biological assays. The entire protocol, from mixing to purified conjugate, can be completed in 3-4 hours.
Copper toxicity to RNA is the principal limitation of CuAAC and the main reason researchers consider copper-free alternatives. The mechanism of damage involves redox cycling of copper between Cu(I) and Cu(II), which generates superoxide and hydroxyl radicals that abstract hydrogen atoms from the RNA ribose ring, causing strand scission. The extent of damage depends on copper concentration, reaction time, and the presence of protective ligands. With optimized THPTA protocols (100 micromolar copper, 1-2 hour reaction), RNA degradation is typically minimal and undetectable by denaturing PAGE. For RNAs that remain sensitive even under optimized conditions, such as those with extensive secondary structure or those required at high purity, copper-free SPAAC or IEDDA chemistry is recommended. An alternative strategy is to perform CuAAC on a protected RNA precursor, deprotecting after conjugation, though this adds synthetic steps.
Strain-promoted azide-alkyne cycloaddition eliminates the copper catalyst by replacing the terminal alkyne with a cyclooctyne, an eight-membered ring that carries approximately 18 kcal/mol of ring strain. This strain energy lowers the activation barrier for the [3+2] cycloaddition sufficiently that the reaction proceeds spontaneously at room temperature without any catalyst. SPAAC is therefore inherently biocompatible: there is no metal to remove after conjugation, no risk of copper-induced RNA damage, and the reaction can even be performed in cell culture media or in the presence of live cells.
The rate of SPAAC conjugation is determined primarily by the structure of the cyclooctyne. First-generation cyclooctyne (OCT) reacts with azides with a second-order rate constant of approximately 2.4 x 10(-3) M(-1)s(-1), requiring overnight incubations. The introduction of electron-withdrawing fluorine atoms adjacent to the alkyne, as in difluorinated cyclooctyne (DIFO), increases the rate approximately 30-60 fold by lowering the LUMO energy of the alkyne. Dibenzo-fused cyclooctynes such as DIBO and DIBAC (also known as DBCO or ADIBO) achieve additional rate enhancement through aryl ring conjugation and are now the most commonly used SPAAC reagents, with rate constants of 0.1-1 M(-1)s(-1). Biarylazacyclooctynone (BARAC) pushes rates to approximately 1-10 M(-1)s(-1) but suffers from limited stability. DBCO (dibenzocyclooctyne) phosphoramidites are commercially available for automated oligonucleotide synthesis, making SPAAC accessible to any laboratory with solid-phase synthesis capability. DBCO-sulfo-NHS esters similarly enable DBCO installation on amine-containing peptides. The trade-off for higher reactivity is increased hydrophobicity: DBCO and BARAC groups are large, polycyclic, and hydrophobic, which can reduce conjugate solubility and promote non-specific binding to serum proteins. For in vivo applications, more hydrophilic cyclooctyne derivatives such as those incorporating sulfonate or PEG groups are preferred.
A SPAAC conjugation is operationally simpler than CuAAC: the azide-modified peptide and DBCO-modified RNA are combined at 20-50 micromolar in PBS or HEPES buffer (pH 7.0-7.5), and the mixture is incubated at room temperature or 37 degrees Celsius for 4-16 hours. No other reagents are required. The reaction reaches higher conversion at 37 degrees Celsius, and gentle agitation is recommended for reactions exceeding 2 hours. Because there are no catalysts or reducing agents to remove, purification can be as simple as a desalting column or ethanol precipitation to exchange the conjugate into the desired storage buffer. The primary limitation is the longer reaction time, which increases the window for RNA hydrolysis, especially for unmodified RNA. Working under RNase-free conditions and including EDTA (1 mM) in the conjugation buffer mitigates this risk. For time-sensitive applications, SPAAC can be run at higher concentrations (100-200 micromolar) to accelerate conversion, with the understanding that aggregation risk increases for hydrophobic DBCO-RNA intermediates at higher concentrations.
Inverse electron-demand Diels-Alder (IEDDA) ligation between a tetrazine and a strained alkene, most commonly trans-cyclooctene (TCO), is the fastest bioorthogonal reaction available, with second-order rate constants reaching 10(6) M(-1)s(-1) for optimized tetrazine-TCO pairs. At these rates, conjugation reaches completion within seconds to minutes at low micromolar or even nanomolar concentrations, making IEDDA uniquely suited for applications where both components are precious, where RNA is exceptionally labile, or where conjugation must be performed under conditions that minimize degradation.
The exceptional speed of IEDDA ligation addresses the RNA stability problem directly: if conjugation is complete in 5 minutes, the RNA is exposed to potentially degrading conditions for 5 minutes instead of hours. For unmodified RNA with a half-life of approximately 30-60 minutes in RNase-free buffer at neutral pH and room temperature, this time reduction translates to negligible degradation. For modified RNA with phosphorothioate or 2'-O-methyl substitutions, the stability advantage of IEDDA is less critical but still operationally convenient. The rate of IEDDA is tunable through tetrazine substitution: electron-withdrawing substituents on the tetrazine accelerate the reaction, while electron-donating substituents slow it. The fastest commercially available tetrazines, typically those with pyridyl or pyrimidyl substituents, achieve rate constants above 10(5) M(-1)s(-1). Slower tetrazines with methyl or phenyl substituents (rate constants 10(2)-10(3) M(-1)s(-1)) provide more time for mixing and handling but still far outpace SPAAC and CuAAC kinetics.
Tetrazine and TCO phosphoramidites are commercially available for 5'-terminal incorporation during solid-phase oligonucleotide synthesis. For peptides, tetrazine-NHS esters and TCO-NHS esters enable installation at amine positions (N-terminus or lysine side chains). For site-specific installation at cysteine residues, tetrazine-maleimide and TCO-maleimide reagents are available. The TCO group, while kinetically powerful, presents a stability consideration: TCO can slowly isomerize from the reactive trans (E) isomer to the unreactive cis (Z) isomer under ambient light or prolonged storage. TCO-modified reagents should be stored at minus 20 degrees Celsius protected from light and used promptly after dissolution. The tetrazine group is more chemically stable but is susceptible to nucleophilic degradation at high pH (above 9) and elevated temperatures. Both handles are compatible with standard peptide deprotection and cleavage conditions (TFA-based cocktails), simplifying synthetic workflows.
An IEDDA conjugation protocol is straightforward: the tetrazine-modified component (typically the peptide, as tetrazine handles are generally more stable during synthesis and storage than TCO handles) and the TCO-modified RNA are combined at the desired concentration in PBS or HEPES buffer. The reaction proceeds spontaneously upon mixing. For the fastest tetrazine-TCO pairs, the reaction is essentially complete by the time the first analytical sample is taken (1-2 minutes). For slower pairs, incubation for 15-60 minutes at room temperature is sufficient. The reaction produces nitrogen gas as the only byproduct from tetrazine decomposition, which is innocuous. Purification by ethanol precipitation or HPLC follows standard protocols. The rapid kinetics mean that HPLC monitoring can be done at a single time point rather than as a time course, simplifying workflow documentation.
Selecting among the three click platforms involves balancing reaction speed, copper exposure, reagent cost, and handle availability. The following comparison provides a practical decision framework for researchers designing a peptide-RNA conjugation strategy.
| Parameter | CuAAC | SPAAC | IEDDA |
| Reaction time | 1-2 hours | 4-16 hours | 1-60 minutes |
| Handle size (atoms) | Azide: 3; Alkyne: 2 | Azide: 3; DBCO: ~30 | Tz: ~15; TCO: ~20 |
| Copper required | Yes (100-500 uM) | No | No |
| RNA damage risk | Moderate (manageable) | Low | Very low (fast kinetics) |
| Phosphoramidite availability | Widely available | Widely available | Available; fewer vendors |
| Relative reagent cost | Low | Moderate-high | High |
Table 2 Practical Comparison of Click Chemistry Platforms for Peptide-RNA Conjugation
SPAAC is the click method of choice when copper must be avoided entirely. This includes conjugations performed directly in cell culture or on cell surfaces, where copper ions would be cytotoxic; reactions where the RNA payload includes oxidation-sensitive modifications such as fluorescent dyes or photoreactive groups; and workflows where post-conjugation copper removal by HPLC or dialysis is impractical. The longer reaction time of SPAAC is acceptable in these contexts because the alternative, copper-induced damage, is more problematic than extended incubation. SPAAC is also the most extensively validated copper-free click chemistry for oligonucleotide conjugation, with commercial DBCO phosphoramidites available from multiple vendors and a well-established literature of successful applications.
IEDDA ligation justifies its higher reagent cost in two scenarios: when conjugation speed directly translates to conjugate quality (e.g., extremely labile RNA that degrades within minutes), and when conjugation must be performed at low concentrations (sub-micromolar) where bimolecular reaction rates become limiting. The 10(4)-10(6) fold rate advantage of IEDDA over SPAAC means that a conjugation that takes overnight with DBCO can be completed in seconds to minutes with tetrazine-TCO, a critical difference when working with precious, degradation-prone RNA constructs. IEDDA is also the only click chemistry that can achieve practical conversion at nanomolar concentrations, making it relevant for conjugation of radiolabeled RNA or for in situ labeling where concentrations are inherently limited.
Despite the availability of copper-free alternatives, CuAAC remains the most commonly used click chemistry for peptide-RNA conjugation for practical reasons: azide and alkyne phosphoramidites are the least expensive click handles; the THPTA-optimized protocol is highly reproducible; the literature contains hundreds of validated examples; and for most research-grade RNAs, the minimal copper-induced damage observed under optimized conditions does not compromise biological activity. CuAAC is the appropriate default choice unless there is a specific reason, copper sensitivity, biological compatibility requirements, or speed constraints, to use SPAAC or IEDDA.
The success of any click conjugation depends on the efficient, site-specific installation of the reactive handles on both the peptide and RNA components. The synthetic strategy for handle installation differs between the two components because peptides and RNA are synthesized by fundamentally different chemistries, solid-phase peptide synthesis (SPPS) using Fmoc chemistry for peptides, and solid-phase phosphoramidite chemistry for RNA.
For RNA, click handles are most commonly introduced as phosphoramidite building blocks during automated solid-phase synthesis. Azide phosphoramidites are available for 5'-terminal, 3'-terminal, and internal incorporation. 5'-Azide and 5'-alkyne phosphoramidites are coupled as the final step of chain assembly, analogous to a standard nucleoside coupling. For internal incorporation, azide- or alkyne-modified deoxyuridine or deoxycytidine phosphoramidites can be placed at any position within the oligonucleotide sequence. The click handles survive standard ammonia deprotection conditions. For RNA that is produced enzymatically (e.g., in vitro transcribed mRNA), post-transcriptional click handle installation is more challenging and typically relies on enzymatic incorporation of modified nucleotide triphosphates bearing click handles at the 5-position of uracil or through post-transcriptional modification of the 5'-cap structure. DBCO and TCO phosphoramidites are similarly compatible with automated synthesis, though their larger size and hydrophobicity can reduce coupling efficiency relative to azide and alkyne phosphoramidites; extended coupling times (5-10 minutes vs the standard 2-3 minutes) are recommended.
Peptide modification with click handles is typically performed at the N-terminus or at lysine side chains using activated ester reagents (NHS or pentafluorophenyl esters of azidoacetic acid, pentynoic acid, DBCO-acid, tetrazine-acid, or TCO-acid). These modifications are compatible with standard Fmoc-SPPS: the click handle can be introduced as the final coupling step before cleavage, or it can be introduced post-synthetically after cleavage and purification. Site-specific incorporation of non-natural amino acids bearing click handles, such as azidolysine, azidohomoalanine, or propargylglycine, during SPPS provides the highest level of positional control and is preferred when the conjugation site must be at a specific residue. For cysteine-directed conjugation, azide-maleimide, DBCO-maleimide, and tetrazine-maleimide heterobifunctional reagents allow site-specific handle installation at engineered cysteine positions.
Azide and terminal alkyne handles are chemically robust: they survive standard SPPS cleavage (TFA), HPLC purification, and long-term storage as lyophilized solids at minus 20 degrees Celsius. DBCO handles are stable to TFA and HPLC but should be stored protected from light and used within weeks of dissolution due to gradual hydrolysis of the strained alkyne. TCO handles are the most labile: isomerization from the reactive trans to the unreactive cis form occurs slowly at neutral pH and is accelerated by light and by thiols that catalyze isomerization. TCO-modified peptides and RNA should be used promptly after synthesis and stored as lyophilized solids at minus 80 degrees Celsius when extended storage is unavoidable. Tetrazines are stable to TFA and most HPLC conditions but degrade slowly in aqueous buffers above pH 8, so tetrazine-modified components should be dissolved in slightly acidic buffers (pH 5-6) if prolonged handling is anticipated.
Despite the reputation of click chemistry for reliability, peptide-RNA click conjugations can encounter several practical problems. Systematic troubleshooting, guided by an understanding of the underlying chemistry, resolves most issues.
RNA degradation during CuAAC manifests as a smear below the conjugate band on denaturing PAGE. If degradation is observed, the following interventions should be attempted in order: increase the THPTA:copper ratio from 5:1 to 10:1; reduce the copper concentration from 500 micromolar to 100 micromolar; add the radical scavenger aminoguanidine (5 mM) to the reaction; degas the buffer by argon sparging to reduce dissolved oxygen; and if degradation persists, switch to SPAAC or IEDDA. A control reaction, RNA incubated with copper/THPTA/ascorbate without peptide, should be run in parallel to confirm that degradation is copper-mediated rather than due to RNase contamination or buffer conditions.
Incomplete conversion in CuAAC is most often caused by oxygen-mediated re-oxidation of Cu(I) to Cu(II) before the catalytic cycle can complete. Using thoroughly degassed buffers, increasing the sodium ascorbate concentration (from 5 mM to 10-25 mM), and performing the reaction under an argon atmosphere address this. For SPAAC, incomplete conversion usually indicates that the DBCO handle has hydrolyzed during storage or that the reaction concentration is too low for the kinetics; using freshly aliquoted DBCO reagent and increasing the concentration to 50-100 micromolar typically restores conversion. For IEDDA, incomplete conversion is rare at reasonable concentrations but can indicate TCO isomerization to the unreactive cis form; using freshly prepared TCO reagent or switching to a dioxolane-fused TCO (dTCO) with improved stability resolves this.
DBCO-modified RNA and TCO-modified RNA can be significantly more hydrophobic than unmodified RNA, leading to aggregation or non-specific adsorption during handling. Adding 10-20 percent acetonitrile or DMF to the conjugation buffer, reducing the concentration, and adding 0.01-0.05 percent non-ionic detergent (Tween-20 or Triton X-100) can maintain solubility. For DBCO-RNA, which is particularly hydrophobic, the conjugate itself may also aggregate after purification; storing the conjugate in 20-30 percent acetonitrile or incorporating a short PEG spacer between the DBCO group and the RNA during synthesis can improve solubility.
The homogeneous, site-specifically defined conjugates produced by click chemistry enable research applications that demand precise molecular characterization. The following examples illustrate how click-ligated peptide-RNA constructs support experimental designs that are difficult or impossible with less controlled conjugation methods.
When cellular uptake or intracellular trafficking is quantified, researchers need to know that every conjugate molecule has the same structure, the same number of peptides per RNA, attached at the same position. Click chemistry provides this structural certainty. Conjugates produced by SPAAC or IEDDA, where every conjugate molecule carries a single triazole or pyridazine linkage at a defined RNA position, eliminate the confounding variable of positional or stoichiometric heterogeneity. This enables rigorous comparison of, for example, the uptake efficiency of a CPP-siRNA conjugate when the CPP is attached at the siRNA 5'-sense-strand terminus versus the 3'-sense-strand terminus, with confidence that structural differences are the only variable.
Monitoring peptide-RNA dissociation, relevant for disulfide-linked constructs that release the RNA cargo in the cytoplasm, benefits from dual-fluorescent labeling strategies. Click chemistry enables orthogonal dual labeling: one click reaction attaches the peptide bearing a donor fluorophore, and a second orthogonal chemistry attaches an acceptor fluorophore to the RNA. Alternatively, the peptide and RNA can carry orthogonal click handles (e.g., azide on the peptide, tetrazine on the RNA) and be conjugated in a single step. The resulting dual-labeled conjugate enables FRET-based monitoring of peptide-RNA proximity: FRET signal is high when peptide and RNA are associated and decreases upon linker cleavage or dissociation.
Click chemistry's quantitative yields make it practical to build multivalent constructs where multiple copies of a peptide are attached to a single RNA scaffold. By incorporating multiple azide or alkyne handles at defined positions along the RNA and reacting with the complementary peptide partner, researchers can create conjugates with defined peptide valency, 2:1, 4:1, or higher, to study how peptide copy number affects cellular uptake, receptor clustering, or avidity. These studies would be impractical with conventional conjugation chemistries due to the difficulty of separating positional isomers and partially conjugated intermediates.
Successful click chemistry conjugation of peptides to RNA depends on the quality of both the starting materials, the azide/alkyne/DBCO/TCO/tetrazine-modified peptide and RNA, and the execution of the click reaction itself. Partnering with a manufacturer experienced in both click chemistry peptide synthesis and peptide-oligonucleotide conjugation ensures that click handles are installed at the optimal positions, with verified incorporation efficiency, and that the conjugation reaction is performed under conditions that maximize yield while preserving RNA integrity.
An experienced supplier can advise on the selection of the appropriate click platform, CuAAC, SPAAC, or IEDDA, based on the specific peptide sequence, RNA format, and intended application. For CuAAC projects, the supplier should optimize the copper-to-ligand ratio and demonstrate RNA integrity after conjugation by HPLC or PAGE. For SPAAC and IEDDA projects, handle stability and reaction completion should be verified by analytical methods before the conjugate is released. Post-conjugation purification by HPLC and characterization by LC-MS should be standard deliverables, providing the researcher with a structurally verified conjugate ready for biological testing.
For research programs that require multiple conjugates, for example, a panel of CPP variants attached to the same siRNA, or the same peptide attached to different RNA sequences, a manufacturer with established click chemistry workflows can produce the entire panel with consistent quality and documented batch records. This consistency is particularly valuable when comparing biological results across conjugates, as it eliminates variability in conjugate quality as a confounding factor in structure-activity analysis.
If you are planning a click chemistry-based peptide-RNA conjugation project, contact our team to discuss your design requirements or request a custom quotation.
Click chemistry is bioorthogonal: the reactive handles (azides, alkynes, cyclooctynes, tetrazines, and TCO) are absent from natural biomolecules and do not cross-react with peptide side chains or RNA nucleobases. This eliminates side reactions that complicate conventional methods, enabling near-stoichiometric coupling with a single, well-defined product. Reactions proceed efficiently in aqueous solution at neutral pH and moderate temperatures, preserving RNA integrity.
CuAAC (copper-catalyzed azide-alkyne cycloaddition) uses a copper(I) catalyst to accelerate the reaction between terminal alkynes and azides, forming a 1,2,3-triazole linkage. It is cost-effective because simple alkyne reagents are inexpensive, but copper ions can generate reactive oxygen species that damage RNA. SPAAC (strain-promoted azide-alkyne cycloaddition) uses cyclooctyne derivatives that react with azides without a catalyst due to ring strain, eliminating copper-related RNA damage at the cost of slightly slower kinetics and more expensive reagents.
The IEDDA reaction between tetrazine and trans-cyclooctene (TCO) is the fastest bioorthogonal reaction available. Reactions can reach completion within minutes at low micromolar concentrations, making IEDDA ideal for conjugating sensitive RNA substrates where extended reaction times risk degradation. This is orders of magnitude faster than CuAAC or SPAAC, which typically require hours for complete conversion.
On peptides, azide or alkyne handles are typically installed during solid-phase peptide synthesis (SPPS) using commercially available unnatural amino acids or terminal capping reagents. On RNA, click handles are introduced during solid-phase oligonucleotide synthesis at the 5'-terminus, 3'-terminus, or internal positions using modified phosphoramidite building blocks. Post-synthetic installation using amine-to-azide or thiol-to-alkyne conversion reagents is also possible for both components.
References